[go: up one dir, main page]

WO1999058113A3 - Nouvelle formulation contenant de la paroxetine - Google Patents

Nouvelle formulation contenant de la paroxetine Download PDF

Info

Publication number
WO1999058113A3
WO1999058113A3 PCT/GB1999/001520 GB9901520W WO9958113A3 WO 1999058113 A3 WO1999058113 A3 WO 1999058113A3 GB 9901520 W GB9901520 W GB 9901520W WO 9958113 A3 WO9958113 A3 WO 9958113A3
Authority
WO
WIPO (PCT)
Prior art keywords
formulation containing
novel formulation
containing paroxetine
paroxetine
hemihydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB1999/001520
Other languages
English (en)
Other versions
WO1999058113A2 (fr
Inventor
David Philip Elder
Graham Stanley Leonard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AU39409/99A priority Critical patent/AU3940999A/en
Priority to APAP/P/2000/002019A priority patent/AP2000002019A0/en
Priority to CA002331871A priority patent/CA2331871A1/fr
Priority to EP99922302A priority patent/EP1077682A2/fr
Priority to JP2000547965A priority patent/JP2002514591A/ja
Priority to KR1020007012706A priority patent/KR20010043574A/ko
Priority to SK1714-2000A priority patent/SK17142000A3/sk
Priority to EA200001174A priority patent/EA200001174A1/ru
Priority to IL13959499A priority patent/IL139594A0/xx
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to PL99344573A priority patent/PL344573A1/xx
Priority to BR9910401-6A priority patent/BR9910401A/pt
Publication of WO1999058113A2 publication Critical patent/WO1999058113A2/fr
Publication of WO1999058113A3 publication Critical patent/WO1999058113A3/fr
Priority to NO20005683A priority patent/NO20005683L/no
Anticipated expiration legal-status Critical
Priority to BG105010A priority patent/BG105010A/xx
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne un chlorhydrate de paroxétine, sous une forme autre qu'un semi-hydrate, que l'on formule en comprimés dans des conditions telles qu'aucune conversion de la paroxétine en son semi-hydrate n'est détectable au cours du processus de fabrication des comprimés.
PCT/GB1999/001520 1998-05-13 1999-05-13 Nouvelle formulation contenant de la paroxetine Ceased WO1999058113A2 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IL13959499A IL139594A0 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
CA002331871A CA2331871A1 (fr) 1998-05-13 1999-05-13 Nouvelle formulation contenant de la paroxetine
EP99922302A EP1077682A2 (fr) 1998-05-13 1999-05-13 Nouvelle formulation contenant de la paroxetine
JP2000547965A JP2002514591A (ja) 1998-05-13 1999-05-13 新規なパロキセチンを含む処方
KR1020007012706A KR20010043574A (ko) 1998-05-13 1999-05-13 파록세틴을 함유하는 신규 제형
SK1714-2000A SK17142000A3 (sk) 1998-05-13 1999-05-13 Hydrochlorid paroxetínu vo forme inej než hemihydrát formulovaný do tabliet, spôsob výroby tabliet hydrochloridu paroxetínu a súprava zahrnujúca takéto tablety
EA200001174A EA200001174A1 (ru) 1998-05-13 1999-05-13 Новая готовая препаративная форма, содержащая пароксетин
AU39409/99A AU3940999A (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
PL99344573A PL344573A1 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
APAP/P/2000/002019A AP2000002019A0 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine.
BR9910401-6A BR9910401A (pt) 1998-05-13 1999-05-13 Nova formulação contendo paroxetina
NO20005683A NO20005683L (no) 1998-05-13 2000-11-10 Ny formulering inneholdende paroxetin
BG105010A BG105010A (en) 1998-05-13 2000-11-30 Medicamentous form containing paroxetine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9810181.9 1998-05-13
GBGB9810181.9A GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations

Publications (2)

Publication Number Publication Date
WO1999058113A2 WO1999058113A2 (fr) 1999-11-18
WO1999058113A3 true WO1999058113A3 (fr) 2000-02-17

Family

ID=10831927

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1999/001520 Ceased WO1999058113A2 (fr) 1998-05-13 1999-05-13 Nouvelle formulation contenant de la paroxetine

Country Status (20)

Country Link
EP (1) EP1077682A2 (fr)
JP (1) JP2002514591A (fr)
KR (1) KR20010043574A (fr)
CN (1) CN1308521A (fr)
AP (1) AP2000002019A0 (fr)
AU (1) AU3940999A (fr)
BG (1) BG105010A (fr)
BR (1) BR9910401A (fr)
CA (1) CA2331871A1 (fr)
EA (1) EA200001174A1 (fr)
GB (1) GB9810181D0 (fr)
HU (1) HUP0102064A2 (fr)
ID (1) ID28019A (fr)
IL (1) IL139594A0 (fr)
NO (1) NO20005683L (fr)
PL (1) PL344573A1 (fr)
SK (1) SK17142000A3 (fr)
TR (1) TR200003350T2 (fr)
WO (1) WO1999058113A2 (fr)
ZA (1) ZA200006562B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580302B2 (en) 2000-11-20 2013-11-12 Warner Chilcott Company, Llc Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
NZ532432A (en) * 2001-10-22 2005-02-25 Synthon Bv N-formyl paroxetine compounds and their use in a synthetic route for obtaining paroxetine
GB2636182A (en) * 2023-12-04 2025-06-11 Novumgen Ltd An orally disintegrating tablet of paroxetine and its process of preparation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995016448A1 (fr) * 1993-12-15 1995-06-22 Smithkline Beecham Plc Comprimes de paroxetine et leur procede de preparation
WO1998009963A1 (fr) * 1996-09-09 1998-03-12 Pentech Pharmaceuticals, Inc. Composition de paroxetine amorphe
WO1998031365A1 (fr) * 1997-01-15 1998-07-23 Smithkline Beecham Plc Compositions a base de paroxetine
WO1999032092A1 (fr) * 1997-12-19 1999-07-01 Smithkline Beecham Corporation Comprimes a dispersion rapide

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995016448A1 (fr) * 1993-12-15 1995-06-22 Smithkline Beecham Plc Comprimes de paroxetine et leur procede de preparation
WO1998009963A1 (fr) * 1996-09-09 1998-03-12 Pentech Pharmaceuticals, Inc. Composition de paroxetine amorphe
WO1998031365A1 (fr) * 1997-01-15 1998-07-23 Smithkline Beecham Plc Compositions a base de paroxetine
WO1999032092A1 (fr) * 1997-12-19 1999-07-01 Smithkline Beecham Corporation Comprimes a dispersion rapide

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580302B2 (en) 2000-11-20 2013-11-12 Warner Chilcott Company, Llc Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US9089492B2 (en) 2000-11-20 2015-07-28 Warner Chilcott Company, Llc Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures

Also Published As

Publication number Publication date
KR20010043574A (ko) 2001-05-25
IL139594A0 (en) 2002-02-10
WO1999058113A2 (fr) 1999-11-18
ID28019A (id) 2001-05-03
BG105010A (en) 2001-07-31
AU3940999A (en) 1999-11-29
HUP0102064A2 (hu) 2002-05-29
CA2331871A1 (fr) 1999-11-18
TR200003350T2 (tr) 2001-03-21
JP2002514591A (ja) 2002-05-21
GB9810181D0 (en) 1998-07-08
BR9910401A (pt) 2001-01-09
AP2000002019A0 (en) 2000-12-31
EA200001174A1 (ru) 2001-06-25
NO20005683L (no) 2000-12-05
PL344573A1 (en) 2001-11-05
CN1308521A (zh) 2001-08-15
NO20005683D0 (no) 2000-11-10
EP1077682A2 (fr) 2001-02-28
ZA200006562B (en) 2002-02-13
SK17142000A3 (sk) 2001-06-11

Similar Documents

Publication Publication Date Title
CA2257303A1 (fr) Formes posologiques biconvexes a desintegration rapide
HUP0100394A3 (en) 2-phenyl substituted imidazotriazinones, process for their preparation and pharmaceutical compositions thereof
ZA200200609B (en) Process for producing phenyl-alkanes compositions produced thereform, and uses thereof.
HUP0204496A3 (en) Novel piperidine compounds and pharmaceutical compositions containing the same and process for preparation the same
AU2001234993A1 (en) A process for forming a semiconductor structure
HUP0002843A3 (en) New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them
MXPA02004119A (es) Nuevos ciclopropanos como antagonistas de cgrp, medicamentos que contienen estos compuestos y metodo para obtencion de los mismos.
CA2365412A1 (fr) Formes posologiques solides de ribavirine administrables par voie orale et methode de fabrication de ces produits
AU2002305495A1 (en) Process for lactose conversion to polyols
PL359373A1 (en) New substituted phthalides, a process for their preparation and pharmaceutical compositions containing them
CA2433366A1 (fr) Base libre d'amlodipine
HUP0104272A3 (en) New cyclobutendione compounds, a process for their preparation and pharmaceutical compositions containing them
WO1999058116A3 (fr) Nouvelle formulation contenant de la paroxetine
WO1999058113A3 (fr) Nouvelle formulation contenant de la paroxetine
WO2000055287A3 (fr) Pastilles de detergent parfumees
ZA200105300B (en) 1,1- and 1,2-disubstituted cyclopropane compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200100565B (en) Benzenesulfonamide compounds, a process for their preparation and pharmaceutical compositions containing them.
HUP0202379A3 (en) New compounds, process for producing them and pharmaceutical compositions containing them
AU2001294246A1 (en) Novel aliphatic compounds, process for their preparation and their usage
CA2370956A1 (fr) Procede de caustification de solutions alcalines
HU0105328D0 (en) Novel bicyclic amino-pirazinone compounds, a process for their preparation and pharmaceutical compositions containing them
AU9437698A (en) Compressed chloramine-t tablets and method for the production thereof
ZA200106203B (en) Benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them.
HUP0302620A3 (en) Novel pharmaceutical compositions having an antidiabetic action, and process for their preparation
AU2001268641A1 (en) Cleaning tablets, and a process for the manufacture of the cleaning tablets

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99808325.9

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 139594

Country of ref document: IL

ENP Entry into the national phase

Ref document number: 2331871

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 17142000

Country of ref document: SK

Ref document number: PV2000-4186

Country of ref document: CZ

Ref document number: 508089

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2000/06562

Country of ref document: ZA

Ref document number: PA/a/2000/011154

Country of ref document: MX

Ref document number: 2000/03350

Country of ref document: TR

Ref document number: 1020007012706

Country of ref document: KR

Ref document number: 200006562

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 39409/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1999922302

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 200001174

Country of ref document: EA

WWP Wipo information: published in national office

Ref document number: 1999922302

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09700269

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: PV2000-4186

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1020007012706

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1999922302

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: PV2000-4186

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1020007012706

Country of ref document: KR